Hester Biosciences vs Peers
- Market cap
- ₹1,750 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,481.18 – ₹2,777.22
Hester Biosciences ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Hester Biosciences. Its P/E of 22.5 compares with a peer median of 22.5.
Hester Biosciences vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Hester Biosciences | 2,057.20 | -5.08% | 1,750 | 22.5 | 2.85 | 14.5% | +18.5% |
| Hester Biosciences | 2,057.20 | -5.08% | 1,750 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Hester Biosciences peer comparison — frequently asked questions
Who are Hester Biosciences' competitors?
Hester Biosciences' listed peers in Drug Manufacturers - Specialty & Generic include Hester Biosciences, ranked here by market capitalisation.
How does Hester Biosciences' P/E compare with its peers?
Hester Biosciences trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Hester Biosciences' peers?
By market capitalisation, the largest company in the group is Hester Biosciences at ₹1,750 crore, against ₹1,750 crore for Hester Biosciences.
Same Data For Peers
Trade Hester Biosciences With ATS
Track HESTERBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.